Jaclyn R. Patterson

Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic

Andrea B. Sherk, Daniel E. Frigo, Christine G. Schnackenberg et al. · Cancer Research · 2008 · 214 citations · Full text

Medicine, Molecular Biology, Oncology +17

Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)

Carl Brooks, Linda S. Barton, David J. Behm et al. · ACS Medicinal Chemistry Letters · 2019 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors

Marlys Hammond, David G. Washburn, Tram H. Hoang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists

William McCalmont, Tiffany N. Heady, Jaclyn R. Patterson et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 43 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Investigation into the structure–activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists

William McCalmont, Jaclyn R. Patterson, Michael A. Lindenmuth et al. · Bioorganic & Medicinal Chemistry · 2005 · 33 citations

Medicine, Medicinal Chemistry, Pharmacology +14